1 WHO/Unicef/The World Bank，State of the world’s vaccines and immunization 2002，World Heslth Organization Department of Vaccine and Biologicals, Geneva ,2002.95~96
2 Curtiss R I, Carkineau C A. Oral innunization by transgenic plants. World Plant Application，1990，90:107~111
3 庞伟,侯宗柳.转基因植物疫苗研究进展.中国天然药物,2004,2(3):141~144
4 Stephen J, Streatfield, John A. Howard,Plant-based vaccine. International Journal for purasitology, 2003,33:479~493
5 Haq T A, Masson H S, Clements J D, et al. immunization with a recombinant bacrerial antigen produced inransgenic plants. Scinence, 1995, 268:714~716
6 Mason H S, Haq T A, Clements J D, et al. Edible vaccine protects mice against Escherichia coil heat-labile enterotoxin (LT):potatoes espressing asynthetid LT-B gene. Vaccine, 1998, 16:1336~1343
7 Lauterslager T G M, Florack D E A, et al. Oral immunization of na?ve and primed animals with transgenic potato tubers espressing LT-B. Vaccine, 2001, (19):3661~3670
8 Streatield S J, Jilka J M, et al. Plant-based vaccines: unique advantages. Vaccine,2001,19:2742~2748
9 Streatfield S J, Mayor J M, Barker D K, et al. Development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In Vitro Cell. Dev. Biol. Plant, 2002,38:11~17
10 Arakawa T, Chong D K X, Merritt J L, et al. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic, 1997,6:403~413
11 Arakawa T, Chong D K X., Langridge W H R. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotechnol, 1998,16:292~297
12 Daniell H, Lee S B, Panchai T, et al. Expression of the native cholera toxin B subunit gene and assembly of functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol, 2001,311:1001~1009
13 Jani D, Singh M L., Mohammad Rizwan-ul-Haq Q, et al. Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res., 2002,11:447~454
14 Aziz M A, Sikriwal D, Singh S, et al. Transformation of an edible crop with the pagA gene of Bacillus anthracis. FASEB J. 2005 9:1501~1503
15 Richter L J, Thanavala Y, Arntzen C J, et al. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnology, 2000,18:1167~1171
16 Kapusta J, Modelska A, Figlerowicz M, et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J, 1999,13:1796~1799
17 Ehsani P, Khabiri A, Domansky N N. Polypeptides of hepatitis B surface antigen produced in transgenic potato. Gene,1997,190:107~111
18 Smith M L, Keegan M E, Mason H S, et al. Factors important in the extraction, stability and in vitro assembly of the hepatitis B surface antigen derived from recombinant plant systems. Biotechnology Progress, 2002,18:538~550
19 Smith M L, Mason H S, Shuler M L. Hepatitis B surface antigen (HbsAg) expression in plant cell culture: kinetics of antigen accumulation in batch culture and its intracellular form. Biotechnol. Bioeng, 2002,80:812~822
20 Nemchinov L G, Liang T J, Rifaat, et al. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch. Virol,2000,145:2557~2573
21 Mason H S, Ball J M, Shi J J, et al.. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl Acad. Sci. USA,1996,93:5335~5340
22 Tacket C O, Mason H S, Losonsky, G, et al. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis.,2000,182:302~305
23 Dong JL, Liang BG, Jin YS, et al. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. Virology. 2005 339(2):153~163
24 Ashraf S, Singh PK, Yadav DK, et al. High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol. 2005 119(1):1~14
25 Yusibov V, Modelska A, Steplewski K, et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl Acad. Sci. USA, 1997, 94:5784~5788
26 Yusibov V, Hooper D C, Spitsin S V, et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine, 2002,20:3155~3164
27 Wigdorovitz A, Carrillo C, Dus Santos M J, et al. Induction of a protective antibody response to foot and mouth disease in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology, 1999, 255:347~353
28 Dus Santos M.J., Wigdorovitz A., Trono, K., Rios, R.D, et al. A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine, 2002, 20:1141–1147
29 Usha R, Rohll J B, Spall V E, et al. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology, 1993,197:366~374
30 Wigdorovitz A, Perez Filgueira D M, et al. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1,Virology ,1999,264:85~91
31 Dus Santos MJ, Wigdorovitz A. Expression of foot and mouth disease virus antigens in transgenic plants. Rev Sci Tech,2005,24(1):175~187
32 Gomez N, Wigdorovitz A, Castanon S, et al. Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus. Arch. Virol, 2000,145:1725~1732
33 Tuboly T, Yu W, Bailey A, Degrandis S, et al. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine, 2000,18:2023~2028
34 Lamphear B J, Streatfield S J, Jilka J M, et al. Delivery of subunit vaccines in maize seed. J. Controlled Release, 2002,85:169~180
35 Dalsgaard K, Uttenthal A, Jones T D, et al. Plant-derived vaccine protects target animals against a viral disease. Nat. Biotechnol.,1997,15: 248~252
36 Castanon S, Marin M S, Martin-Alonso J M, et al. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J. Virol.,1999,73:4452~4455
37 Berinstein A, Vazquez-Rovere C, Asurmendi S, et al. Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine, 2005,11:3450~3458
38 YuJ, Langridge W H R. A plant-based multicomponent vaccine protects mice from enteric diseas. Nat.Biotechnol, 2001,19,548~552
39 Ma J K C. Genes, Greens and vaccines. Nat. Biotechnol.,2000,18:1141~1142
40 Daniell H, Lee S B, Panchal T, et al. Expression of the native cholero toxin choroplasts. J Mol Biol, 2001, 311(5):1001~1009
41 Tregoning J S, Nixon P, Kuroda H, et al. Exprenssion of tetanus toxin fragment C in tobaco chloroplasts,Nucleic Acids Res, 2003, 31(4):1174~1179
42 Lerouge P, et al. N-glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards a humanization of plant N-glycans. Curr. Pharmacol. Biotechnology,2000,1:347~354
43 Bakker H, et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc. Natl. Acad. Sci. U. S. A, 2001,98:2899~2904
44 王宝琴,张永光,王小龙.转基因植物疫苗与转基因植物抗体的研究近展.中国兽医科技,2003,33(9):29~33
45 朱国萍,徐冲. 植物生物反应器生产绿色疫苗研究进展. 生物工程进展,2002, 22(2):70~72
46 Rigano M, Walmsley A M. Expression systems and developments in plant-made vaccines. Immunology and Cell Biology, 2005,83(3):271~277
|
